Elanco Animal Health (ELAN) Times Interest Earned (2018 - 2026)
Elanco Animal Health (ELAN) reported Times Interest Earned of $5.11 for Q1 2026, down 14.91% on a YoY basis from $6.0 in Q1 2025, and up 1028.23% sequentially from -$0.55 in Q4 2025.
Elanco Animal Health (ELAN) Times Interest Earned (2018 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 9 years of Times Interest Earned data on file, last reported at $5.11 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 14.91% year-over-year to $5.11; the trailing twelve-month figure through Mar 2026 stood at $2.66 (up 193.01% YoY), and the FY2025 full-year result was $2.54, up 149.56% from the prior year.
- Times Interest Earned climbed to $5.11 in Q1 2026, from -$0.55 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $6.0 in Q1 2025 to a low of -$22.0 in Q3 2023.
- A 5-year average of -$4.18 and a median of -$5.56 in 2022 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned plunged 189.92% in 2023 and surged 178.73% in 2025, its largest moves.
- Tracing ELAN's Times Interest Earned over 5 years: stood at -$8.66 in 2022, then soared by 56.07% to -$3.8 in 2023, then slumped by 35.59% to -$5.16 in 2024, then soared by 89.34% to -$0.55 in 2025, then jumped by 1028.23% to $5.11 in 2026.
- Business Quant data shows ELAN's Times Interest Earned at $5.11 in Q1 2026, -$0.55 in Q4 2025, and $2.73 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 0.18 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 5.11 |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.11 |
| Dec 31, 2025 | -0.55 |
| Sep 30, 2025 | 2.73 |
| Jun 30, 2025 | 2.65 |
| Mar 31, 2025 | 6.00 |
| Dec 31, 2024 | -5.16 |
| Sep 30, 2024 | 1.16 |
| Jun 30, 2024 | -8.11 |
| Mar 31, 2024 | -7.62 |
| Dec 31, 2023 | -3.80 |
| Sep 30, 2023 | -22.00 |
| Jun 30, 2023 | -6.93 |
| Mar 31, 2023 | -6.03 |
| Dec 31, 2022 | -8.66 |
| Sep 30, 2022 | -7.59 |
| Jun 30, 2022 | -6.73 |
| Mar 31, 2022 | -5.56 |
| Dec 31, 2021 | -11.55 |
| Sep 30, 2021 | -10.53 |
| Jun 30, 2021 | -13.13 |